204 related articles for article (PubMed ID: 31003512)
1. Trastuzumab-Modified Gold Nanoparticles Labeled with
Dziawer Ł; Majkowska-Pilip A; Gaweł D; Godlewska M; Pruszyński M; Jastrzębski J; Wąs B; Bilewicz A
Nanomaterials (Basel); 2019 Apr; 9(4):. PubMed ID: 31003512
[TBL] [Abstract][Full Text] [Related]
2.
Cai Z; Chattopadhyay N; Yang K; Kwon YL; Yook S; Pignol JP; Reilly RM
Nucl Med Biol; 2016 Dec; 43(12):818-826. PubMed ID: 27788375
[TBL] [Abstract][Full Text] [Related]
3. Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with
Cędrowska E; Pruszyński M; Gawęda W; Żuk M; Krysiński P; Bruchertseifer F; Morgenstern A; Karageorgou MA; Bouziotis P; Bilewicz A
Molecules; 2020 Feb; 25(5):. PubMed ID: 32106568
[TBL] [Abstract][Full Text] [Related]
4. Dual-Receptor-Targeted (DRT) Radiation Nanomedicine Labeled with
Yook S; Cai Z; Jeong JJ; Lu Y; Winnik MA; Pignol JP; Reilly RM
Mol Pharm; 2020 Apr; 17(4):1226-1236. PubMed ID: 32022567
[TBL] [Abstract][Full Text] [Related]
5. Local Radiation Treatment of HER2-Positive Breast Cancer Using Trastuzumab-Modified Gold Nanoparticles Labeled with
Cai Z; Yook S; Lu Y; Bergstrom D; Winnik MA; Pignol JP; Reilly RM
Pharm Res; 2017 Mar; 34(3):579-590. PubMed ID: 27987070
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin- and Trastuzumab-Modified Gold Nanoparticles as Potential Multimodal Agents for Targeted Therapy of HER2+ Cancers.
Żelechowska-Matysiak K; Wawrowicz K; Wierzbicki M; Budlewski T; Bilewicz A; Majkowska-Pilip A
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985421
[TBL] [Abstract][Full Text] [Related]
7. Improvement of the Effectiveness of HER2+ Cancer Therapy by Use of Doxorubicin and Trastuzumab Modified Radioactive Gold Nanoparticles.
Żelechowska-Matysiak K; Salvanou EA; Bouziotis P; Budlewski T; Bilewicz A; Majkowska-Pilip A
Mol Pharm; 2023 Sep; 20(9):4676-4686. PubMed ID: 37607353
[TBL] [Abstract][Full Text] [Related]
8. Au@
Gharibkandi NA; Wawrowicz K; Majkowska-Pilip A; Żelechowska-Matysiak K; Wierzbicki M; Bilewicz A
EJNMMI Radiopharm Chem; 2023 Oct; 8(1):26. PubMed ID: 37821747
[TBL] [Abstract][Full Text] [Related]
9. Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy.
Gawęda W; Pruszyński M; Cędrowska E; Rodak M; Majkowska-Pilip A; Gaweł D; Bruchertseifer F; Morgenstern A; Bilewicz A
Nanomaterials (Basel); 2020 Oct; 10(10):. PubMed ID: 33092037
[TBL] [Abstract][Full Text] [Related]
10. Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer.
Chattopadhyay N; Cai Z; Pignol JP; Keller B; Lechtman E; Bendayan R; Reilly RM
Mol Pharm; 2010 Dec; 7(6):2194-206. PubMed ID: 20973534
[TBL] [Abstract][Full Text] [Related]
11. Radiation Nanomedicine for EGFR-Positive Breast Cancer: Panitumumab-Modified Gold Nanoparticles Complexed to the β-Particle-Emitter, (177)Lu.
Yook S; Cai Z; Lu Y; Winnik MA; Pignol JP; Reilly RM
Mol Pharm; 2015 Nov; 12(11):3963-72. PubMed ID: 26402157
[TBL] [Abstract][Full Text] [Related]
12. Au@Pt Core-Shell Nanoparticle Bioconjugates for the Therapy of HER2+ Breast Cancer and Hepatocellular Carcinoma. Model Studies on the Applicability of
Wawrowicz K; Majkowska-Pilip A; Gaweł D; Chajduk E; Pieńkowski T; Bilewicz A
Molecules; 2021 Apr; 26(7):. PubMed ID: 33916671
[No Abstract] [Full Text] [Related]
13. Multifunctional Nanoparticles Based on Iron Oxide and Gold-198 Designed for Magnetic Hyperthermia and Radionuclide Therapy as a Potential Tool for Combined HER2-Positive Cancer Treatment.
Żuk M; Podgórski R; Ruszczyńska A; Ciach T; Majkowska-Pilip A; Bilewicz A; Krysiński P
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015306
[TBL] [Abstract][Full Text] [Related]
14. Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine.
Hu N; Yin JF; Ji Z; Hong Y; Wu P; Bian B; Song Z; Li R; Liu Q; Wu F
Cell Physiol Biochem; 2017; 44(6):2158-2173. PubMed ID: 29241186
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analyses of amount and localization of radiosensitizer gold nanoparticles interacting with cancer cells to optimize radiation therapy.
Hatoyama K; Kitamura N; Takano-Kasuya M; Tokunaga M; Oikawa T; Ohta M; Hamada Y; Tada H; Kobayashi Y; Kamei T; Gonda K
Biochem Biophys Res Commun; 2019 Jan; 508(4):1093-1100. PubMed ID: 30551875
[TBL] [Abstract][Full Text] [Related]
16. Trastuzumab-polyethylenimine-polyethylene glycol conjugates for targeting Her2-expressing tumors.
Germershaus O; Merdan T; Bakowsky U; Behe M; Kissel T
Bioconjug Chem; 2006; 17(5):1190-9. PubMed ID: 16984128
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumab.
Ma P; Zhang X; Ni L; Li J; Zhang F; Wang Z; Lian S; Sun K
Int J Nanomedicine; 2015; 10():2173-90. PubMed ID: 25834432
[TBL] [Abstract][Full Text] [Related]
18. In vitro cytotoxicity of 211At-labeled trastuzumab in human breast cancer cell lines: effect of specific activity and HER2 receptor heterogeneity on survival fraction.
Akabani G; Carlin S; Welsh P; Zalutsky MR
Nucl Med Biol; 2006 Apr; 33(3):333-47. PubMed ID: 16631082
[TBL] [Abstract][Full Text] [Related]
19. Label-Free, Rapid and Facile Gold-Nanoparticles-Based Assay as a Potential Spectroscopic Tool for Trastuzumab Quantification.
Alsadig A; Vondracek H; Pengo P; Pasquato L; Posocco P; Parisse P; Casalis L
Nanomaterials (Basel); 2021 Nov; 11(12):. PubMed ID: 34947531
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antiproliferative activity of antibody-functionalized polymeric nanoparticles for targeted delivery of anti-miR-21 to HER2 positive gastric cancer.
Wu FL; Zhang J; Li W; Bian BX; Hong YD; Song ZY; Wang HY; Cui FB; Li RT; Liu Q; Jiang XD; Li XM; Zheng JN
Oncotarget; 2017 Sep; 8(40):67189-67202. PubMed ID: 28978026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
